MK0677

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Alzheimer's DiseaseHip Fracture

Phase 2

Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)

CompletedNCT00074529

Merck Sharp & Dohme LLCAlzheimer's Disease

Start: 2003-10-31End: 2006-01-31Updated: 2015-07-24

Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)

TerminatedNCT00128115

Merck Sharp & Dohme LLCHip Fracture

Start: 2005-09-30End: 2007-08-31Updated: 2016-01-20